Friday, December 11, 2020

FDA Panel Votes in Favor of Pfizer Vaccine

From the story: A federal panel of outside experts on Thursday endorsed a coronavirus vaccine from Pfizer and BioNTech, and recommended the Food and Drug Administration (FDA) move forward with emergency authorization. The panel voted 17-4 with one abstention that safety and efficacy of the vaccine outweigh the risks for use in individuals age 16 and older (The Hill).  

From another story: … executives from UPS and FedEx assured lawmakers that they are ready and prepared to complete one of the biggest logistics challenges in recent history – delivering 660 million COVID-19 vaccine doses nationwide, enough for the required two doses per person (ABC News). 

A look at how the vaccine works (New York Times). 

No comments:

Post a Comment